EP4175632A4 - Formulation comprenant de la vildagliptine et au moins un excipient pharmaceutiquement acceptable - Google Patents

Formulation comprenant de la vildagliptine et au moins un excipient pharmaceutiquement acceptable Download PDF

Info

Publication number
EP4175632A4
EP4175632A4 EP21837553.3A EP21837553A EP4175632A4 EP 4175632 A4 EP4175632 A4 EP 4175632A4 EP 21837553 A EP21837553 A EP 21837553A EP 4175632 A4 EP4175632 A4 EP 4175632A4
Authority
EP
European Patent Office
Prior art keywords
vildagliptin
formulation
pharmaceutically acceptable
acceptable excipient
excipient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21837553.3A
Other languages
German (de)
English (en)
Other versions
EP4175632A1 (fr
Inventor
Vildan TOMBAYOGLU
Arzu PALANTOKEN
Fatih Sunel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanovel Ilac Sanayi ve Ticaret AS
Original Assignee
Sanovel Ilac Sanayi ve Ticaret AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi ve Ticaret AS filed Critical Sanovel Ilac Sanayi ve Ticaret AS
Publication of EP4175632A1 publication Critical patent/EP4175632A1/fr
Publication of EP4175632A4 publication Critical patent/EP4175632A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP21837553.3A 2020-07-06 2021-05-07 Formulation comprenant de la vildagliptine et au moins un excipient pharmaceutiquement acceptable Pending EP4175632A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2020/10700A TR202010700A2 (tr) 2020-07-06 2020-07-06 Vi̇ldagli̇pti̇n ve en az bi̇r farmasöti̇k olarak kabul edi̇lebi̇li̇r eksi̇pi̇yan i̇çeren bi̇r formülasyon
PCT/TR2021/050444 WO2022010436A1 (fr) 2020-07-06 2021-05-07 Formulation comprenant de la vildagliptine et au moins un excipient pharmaceutiquement acceptable

Publications (2)

Publication Number Publication Date
EP4175632A1 EP4175632A1 (fr) 2023-05-10
EP4175632A4 true EP4175632A4 (fr) 2024-08-07

Family

ID=79553558

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21837553.3A Pending EP4175632A4 (fr) 2020-07-06 2021-05-07 Formulation comprenant de la vildagliptine et au moins un excipient pharmaceutiquement acceptable

Country Status (3)

Country Link
EP (1) EP4175632A4 (fr)
TR (1) TR202010700A2 (fr)
WO (1) WO2022010436A1 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210627A1 (en) * 2005-01-18 2006-09-21 Sabine Pfeffer Direct compression formulation and process
CN101106977A (zh) * 2005-01-18 2008-01-16 诺瓦提斯公司 直接压片的配方及方法
US20080193529A1 (en) * 2005-06-10 2008-08-14 James Kowalski Direct Compression Formulation and Process
WO2019219920A1 (fr) * 2018-05-18 2019-11-21 Galenicum Health S.L.U Compositions pharmaceutiques stables d'inhibiteurs de dpp-iv en combinaison avec de la metformine sous la forme de comprimés à libération immédiate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2915528A1 (fr) * 2014-03-06 2015-09-09 Sanovel Ilac Sanayi ve Ticaret A.S. Procédé de formulation de vildagliptine sous atmosphère de gaz inerte

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060210627A1 (en) * 2005-01-18 2006-09-21 Sabine Pfeffer Direct compression formulation and process
CN101106977A (zh) * 2005-01-18 2008-01-16 诺瓦提斯公司 直接压片的配方及方法
US20080193529A1 (en) * 2005-06-10 2008-08-14 James Kowalski Direct Compression Formulation and Process
WO2019219920A1 (fr) * 2018-05-18 2019-11-21 Galenicum Health S.L.U Compositions pharmaceutiques stables d'inhibiteurs de dpp-iv en combinaison avec de la metformine sous la forme de comprimés à libération immédiate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2022010436A1 *

Also Published As

Publication number Publication date
WO2022010436A1 (fr) 2022-01-13
EP4175632A1 (fr) 2023-05-10
TR202010700A2 (tr) 2022-01-21

Similar Documents

Publication Publication Date Title
IL275704A (en) Pharmaceutical formulation for oral administration containing cannabinoids and poloxamer
EP4149470A4 (fr) Formulations pharmaceutiques et leurs utilisations
EP4045480A4 (fr) Formulations pharmaceutiques
BR112015023391A8 (pt) formulações de conjugados anticorpo-droga anti-egfr
AR103246A1 (es) Derivados de fgf21 y sus usos
PH12019501076A1 (en) Pharmaceutical formulations
EP4215208A4 (fr) Association pharmaceutique et son utilisation
ES2850277R1 (es) Composiciones de administración farmacéutica y usos de las mismas
IL311331A (en) Pharmaceutical composition and use thereof
PH12017502322B1 (en) Therapeutic agent for fibrosis
IL288645A (en) Conjugated saponin and vaccine or a pharmaceutical composition containing it
IL289943A (en) Medicinal and/or pharmaceutical compositions for insertion into a blister, preparation and uses
IL299671A (en) Viscosity-reducing excipients and their combinations for high-concentration protein formulations
EP4175632A4 (fr) Formulation comprenant de la vildagliptine et au moins un excipient pharmaceutiquement acceptable
HK1245131A1 (zh) 用於治疗炎症性疾病的包含十六酰胺乙醇pea和番茄红素的组合物
EP3921322C0 (fr) Dérivés d'amine d'imidazoquinoline de phosphore, compositions pharmaceutiques et procédés thérapeutiques correspondants
GB202005282D0 (en) Pharmaceutical Formulations
IL312874A (en) Pharmaceutical composition and use thereof
EP4101466A4 (fr) Composition de dérivés d'acide hyaluronique, composition pharmaceutique et composition conjuguée de médicament-dérivé d'acide hyaluronique
EP4042999C0 (fr) Dispositif récepteur de médicament de formulation orale solide, et appareil d'administration orale le comprenant
EP3965759A4 (fr) Formulation de comprimé comprenant de la lercanidipine et de l'énalapril
IL314206A (en) Pharmaceutical formulation
CR20220587A (es) Formulaciones farmacéuticas
EP4342492A4 (fr) Combinaison pharmaceutique et son utilisation
CL2022001426A1 (es) Formulación pediátrica de liberación inmediata del abridor de canales de potasio ezogabina

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230105

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230708

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20240705

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/20 20060101ALI20240701BHEP

Ipc: A61K 31/40 20060101AFI20240701BHEP

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SANOVEL ILAC SANAYI VE TICARET A.S.